Both share theoretical concerns about pancreatitis (rare) and gallbladder events (related to rapid weight loss)
Furthermore, in addition to counteracting the primary intragastric alcohol-induced stomach lesions, BPC 157 counteracted all other lesions, including those of the brain, heart, lung, liver, and kidney, as well as thrombosis and vascular failure, peripherally and centrally, intracranial, portal, and caval hypertension, and aortal hypotension
Future therapeutic approaches may involve: Microbiome-targeted therapies Gut-derived peptide treatments Personalized nutrition based on microbial composition These emerging strategies reflect a broader shift in metabolic medicine toward addressing root causes rather than simply managing symptoms
Identification of peptide AEDG in the polypeptide complex of the pineal gland